Holland-Frei Cancer Medicine

Գրքի շապիկի երեսը
Robert C. Bast, Jr., Carlo M. Croce, William N. Hait, Waun Ki Hong, Donald W. Kufe, Martine Piccart-Gebhart, Raphael E. Pollock, Ralph R. Weichselbaum, Hongyang Wang, James F. Holland
John Wiley & Sons, 13 մրտ, 2017 թ. - 2008 էջ
Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients.
  • A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease
  • An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies
  • Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics
  • Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs
  • Includes free access to the Wiley Digital Edition providing search across the book, the full reference list with web links, illustrations and photographs, and post-publication updates
 

Բովանդակություն

Principles of psychooncology
Monoclonal serotherapy
Urothelial cancer
Cover
Drug interactions
Dedication
List of contributors
Preface
Hematopoietic cell transplantation
Principles of pediatric oncology
Cancer and pregnancy
Systemic therapy
Psychosocial issues
Cancer and aging
Neoplasms in acquired immunodeficiency
Cancer survivorship new challenge in cancer

Cancer genomelandscapes
Biological hallmarks of cancer
References
Molecular biology genomics proteomics
General techniques
Oncogenes
Disease Sites
Epidemiology Prevention and Detection
Tumor suppressor genes
Epigenetic contributions to human cancer
Management of Cancer Complications
MicroRNA expression in cancer
Aberrant signaling pathways in cancer
Growth factor signaling and cancer therapy
References
Differentiation therapy
References
Cancer stem cells
Cancer and cell death
List of abbreviations
Cancer cell immortality targeting telomerase
Cancer metabolism
Modeling therapy of late or earlystage
Acknowledgments
of genomic medicine
Burnout in oncology
Chemical carcinogenesis
chemical carcinogenesis
References
Endocrine and genetic bases of hormonerelated
Ionizing radiation
Neoplasms of the esophagus
Ultraviolet radiation carcinogenesis
Inflammation and cancer
RNA tumor viruses
Herpesviruses
Papillomaviruses and cervical neoplasia
Hepatitis viruses and hepatoma
Parasites
Chemoprevention of cancer
Nexgen pathology predicting clinical course
Molecular diagnostics in cancer
Systems biology and genomics
Risk behaviors for skin cancer
Principles of imaging
Interventional radiology for the cancer patient
Principles of surgical oncology
cancer patient
Principles of radiation oncology
Principles of medical oncology
Palliative care and pain management
Principles of cancer rehabilitation medicine
Integrative oncology in cancer care
Health services research
Personalized medicine in oncology drug
Preclinical and early clinical development
Tumor growth kinetics
Etiology
Folate antagonists
References
Pyrimidine and purine antimetabolites
Guanine antimetabolites
Alkylating agents and platinum antitumor
Administration dose and schedule
Clinical pharmacology
Other natural products that enhance tubulin
Drug resistance and its clinical circumvention
overcome drug resistance
Cytokines interferons and hematopoietic
Acknowledgment
Vaccines and immunostimulants
References
Cellbased cancer immunotherapy
Cancer gene therapy
DNA topoisomerase targeting drugs
practice?
Neoplasms of the
Neoplasms of the thyroid
Neoplasms of the anus
Diagnosis
Neoplasms of the adrenal cortex
Tumors of the diffuse neuroendocrine
Agents targeting microtubules and mitotic
Cancer of the lung
Malignant pleural mesothelioma
Thymomas and thymic tumors
Acute lymphoblastic leukemia
Principles of dose schedule and combination
Tumors of the heart and great vessels
References
Primary germ cell tumors of the thorax
Carcinoma of the stomach
Diagnosis
Primary neoplasms of the liver
Epithelioid hemangioendothelioma
Gallbladder and bile duct cancer
Neoplasms of the exocrine pancreas
Neoplasms of the small intestine vermiform
Renal cell carcinoma
Neoplasms of the prostate
Tumors of the penis and the urethra
Tumor staging
Pelvic lymphadenectomy
Prognosis
Testis cancer
Staging
Neoplasms of the vulva and vagina
Treatment
Neoplasms of the cervix
Endometrial cancer
Nonepithelial ovarian malignancies
Molar pregnancy and gestational trophoblastic
Subsequent pregnancies
Neoplasms of the breast
Other skin cancers
References
Bone tumors
Soft tissue sarcomas
Chronic myeloid leukemia
Gynecologic sarcomas
Pathology
Chronic lymphocytic leukemia
Malignant melanoma
Treatment of recurrent disease
Hospice
Hodgkin lymphoma
The myelodysplastic syndrome
NonHodgkins lymphoma
Mycosis fungoides and Sézary syndrome
Plasma cell tumors
Myeloproliferative neoplasms essential
Antiemetic therapy
References
Neurologic complications of cancer
Dermatologic complications of cancer
Disparities in cancer care
Hematologic complications and blood bank
Coagulopathic complications of cancer patients
Urologic complications
Cardiac complications
Respiratory complications
Gastrointestinal and hepatic complications
Oral complications of cancer and their
Gonadal complications
Endocrine complications and paraneoplastic
production
Infections in patients with cancer
and humoral immunity
A vision for twentyfirst century healthcare
Scaling
References
Epithelial ovarian fallopian tube

Այլ խմբագրություններ - View all

Common terms and phrases

Հեղինակի մասին (2017)

Robert C. Bast Jr, MD, Vice President for Translational Research, MD Anderson Cancer Center, Houston, TX, USA

Carlo M. Croce, MD, Distinguished University Professor, The John W. Wolfe Chair in Human Cancer Genetics, Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics, The Wexner Medical Center, The Ohio State University, Columbus, OH, USA

William Hait, MD, PhD, Global Head research and Development, Janssen pharmaceutical companies of Johnson and Johnson, NJ, USA

Waun Ki Hong, MD, DMSc, Professor of Thoracic/Head and Neck Medical Oncology, American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine Emeritus, The University of Texas M.D.Anderson Cancer Center, Houston, TX, USA

Donald W. Kufe, MD, Distinguished Physician, Dana-Farber Cancer Institute, Professor of Medicine
Harvard Medical School, Leader, Translational Pharmacology and Early Therapeutic Trials Program
Dana-Farber/Harvard Cancer Center, Boston, MA, USA

Martine Piccart-Gebhart MD PhD, Professor of Oncology, Université Libre de Bruxelles (ULB), Head of the Medicine Department, Jules Bordet Institute, Brussels, Belgium

Raphael E. Pollock, MD, PhD, FACS, Professor and Director, Division of Surgical Oncology, Surgeon in Chief, James Comprehensive Cancer Center, Surgeon in Chief, The Ohio State University Health System, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Ralph R. Weichselbaum, MD, Daniel K. Ludwig Professor Chair Dept of Radiology and Cellular Oncology University of Chicago Hospital Director Chicago Tumor Institute, IL, USA

Dr Hongyang Wang, Professor and Director, National Center for Liver Cancer, China; and Eastern Hepatobiliary Surgery Hospital, Shanghai, China

James F. Holland, MD, ScD (hc), Distinguished Professor of Neoplastic Diseases, Director Emeritus of Derald H.Rutttenberg Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA


ASSOCIATE EDITOR

Fadlo R. Khuri, MD, Executive Associate Dean for Research, Emory University School of Medicine, Atlanta, GA, USA; President, the American University of Beirut, Beirut, Lebanon

Բիբլիոգրաֆիական տվյալներ